Geftinat Tablet

Get a Price/Quote

Product Details:

Indication Non-Small Cell Lung Cancer (NSCLC)
Salt Composition Gefitinib 250mg
Dosage Form Tablet
Feature Targeted therapy for NSCLC, convenient oral dosage form
Ingredients Gefitinib
Application Oral use for targeted cancer therapy
Physical Color/Texture Film-coated tablet, brown
Click to View more

Request to Call Back Send Inquiry

Product Details
Product Description

Geftinat Tablet Product Specifications

Application Oral use for targeted cancer therapy
Fermentation Smell Odorless
Physical Color/Texture Film-coated tablet, brown
Indication Non-Small Cell Lung Cancer (NSCLC)
Storage Instructions Store below 30C, in a dry place, protected from light
Feature Targeted therapy for NSCLC, convenient oral dosage form
Dosage Form Tablet
Shelf Life 24 months
Ingredients Gefitinib
Salt Composition Gefitinib 250mg

Geftinat Tablet Trade Information

Supply Ability 30 Per Day
Delivery Time 1 Week
Sample Available Yes
Main Export Market(s) Central America, Eastern Europe, South America, North America, Africa, Australia, Western Europe, Asia, Middle East
Main Domestic Market All India

Product Description

We have developed ourselves as a reputed organization engaged in offering Geftinat Tablet. It is an effective medication for patients suffering from non-small cell lung cancer. Highly demanded in the nursing homes and hospitals, this tablet is procured from authentic vendors of the market. Geftinat Tablet blocks the activity of chemicals, which increases the growth of cancer cells in the body. We offer this tablet at affordable prices.

Features:

Extended shelf life
Blocks epidermal growth factor receptor
Kills cancer cells

Targeted Therapy for NSCLC

Geftinat Tablet is designed as a targeted treatment for patients diagnosed with Non-Small Cell Lung Cancer. By focusing on specific cancer pathways with Gefitinib, it provides an advanced approach to disease management, offering patients a more defined therapy directed by an oncology specialist.

Convenient Oral Medication

With its film-coated, brown tablet form, Geftinat presents a straightforward oral dosage option. This ease of administration supports regular treatment schedules while maintaining efficacy, offering an alternative to intravenous therapies in cancer management.

Safety and Storage Guidelines

It is essential to follow prescribed instructions from your oncologist, particularly for patients with liver or kidney impairments. The tablets should be stored below 30C, in a dry place, away from light, to ensure potency and safety across its 24-month shelf life.

FAQs of Geftinat Tablet:

Q: How should Geftinat Tablet be taken for effective treatment?

A: Geftinat Tablet should be taken orally, exactly as directed by your oncologist, to ensure optimal targeted therapy for Non-Small Cell Lung Cancer. Do not alter the dosage or schedule without professional guidance.

Q: What is the primary use of Geftinat Tablet?

A: The primary use of Geftinat Tablet is as targeted therapy for Non-Small Cell Lung Cancer (NSCLC). It contains Gefitinib 250 mg, which works against cancer cells by interfering with specific molecular pathways.

Q: When should I avoid taking Geftinat Tablet?

A: You should not take Geftinat Tablet if you have hypersensitivity to Gefitinib or any excipients. Inform your healthcare provider if you have a history of allergic reactions to similar medications.

Q: Where should I store Geftinat Tablets to maintain their quality?

A: Store Geftinat Tablets below 30C, in a dry place protected from light. Proper storage ensures the medication remains potent throughout its 24-month shelf life.

Q: What precautions should I follow when using Geftinat Tablet?

A: Use Geftinat Tablet with caution if you have liver or kidney impairment. Always consult your oncologist before starting or continuing therapy, and report any unusual symptoms promptly.

Q: How does Geftinat Tablet benefit patients with NSCLC?

A: Geftinat Tablet provides targeted therapy by focusing on cancer cell growth mechanisms in NSCLC, offering improved efficacy with a convenient oral form that supports patient compliance and ongoing cancer management.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Tablets' category

Armotraz Anastrozole Tablet Price : 480 INR Shelf Life : 24 months Ingredients : Other , Anastrozole, Excipients Storage Instructions : Store below 30C, keep dry Fermentation Smell : Other, Odorless Feature : Other, Highly selective aromatase inhibitor for improved efficacy Dosage Form : Tablet Salt Composition : Anastrozole 1 mg Indication : Breast cancer in postmenopausal women Application : Other, Oncology, Hormone therapy Physical Color/Texture : Other , White to offwhite, filmcoated tablet Enzyme Types : Other, Aromatase inhibitor Enzymatic Activity : Inhibits aromatase enzyme activity

Send Inquiry

Lysodren Mitotane Shelf Life : 24 months Ingredients : Other , Mitotane Storage Instructions : Store below 25C, protect from moisture Fermentation Smell : Other, Odorless Feature : Other, High potency oral anticancer agent Dosage Form : Tablet Salt Composition : Mitotane 500 mg Indication : Adrenocortical carcinoma Application : Other, Antineoplastic therapy Physical Color/Texture : Other , White, scored tablets Enzyme Types : Other, Steroid biosynthesis inhibitors Enzymatic Activity : Inhibits hormone production (adrenocortical)

Send Inquiry

Gefticip Gefitinib Tablet Price : 1400 INR Shelf Life : 24 months Ingredients : Other , Gefitinib and excipients Storage Instructions : Store below 30C, protect from moisture Fermentation Smell : Other, Odorless Feature : Other, Targeted EGFR tyrosine kinase inhibitor Dosage Form : Tablet Salt Composition : Gefitinib 250 mg Indication : NonSmall Cell Lung Cancer (NSCLC) Application : Other, Oral administration for cancer therapy Physical Color/Texture : Other , White to offwhite, filmcoated tablet

Send Inquiry

Nublexa Tablet Shelf Life : 2 years from date of manufacture Ingredients : Other , Regorafenib and excipients Storage Instructions : Store below 30C, in original packaging, away from moisture and light Fermentation Smell : Other, Odorless Feature : Other, Filmcoated tablet, easy to swallow Dosage Form : Tablet Salt Composition : Regorafenib 40mg Indication : Treatment of metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma Application : Other, Oral administration for cancer therapy Physical Color/Texture : Other , Light pink to pale brown, round tablets Enzyme Types : Other, Not applicable (synthetic multikinase inhibitor)

Send Inquiry

SEND INQUIRY CALL ME FREE